Metagenomi Therapeutics, Inc 10-K for FY2024
Metagenomi Therapeutics, Inc. (MGX)
10-K
2025-03-17
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
Metagenomi Therapeutics, Inc filed this 10-K on March 17, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $52.3M
- up 16.8% from $44.76M a year earlier
- Net loss
- $78.06M
- compared with a net loss of $68.26M a year earlier
- Diluted EPS
- -$2.36
- compared with -$20.05 a year earlier